Internal Reference Number: FOI_8801
Date Request Received: 28/07/2025 00:00:00
Date Request Replied To: 04/08/2025 00:00:00
This response was sent via: By Email
Request Summary: HAE and IG Drugs
Request Category: Companies
| Question Number 1: I am writing to request the following information under the FOIA. If you require any clarification regarding this request, please do not hesitate to contact me. HAE: In the past 3 months [latest 3 months available] how many patients have received the following treatments [for any disease]: Berinert (Human C1-esterase inhibitor) Cinryze (Human C1-esterase inhibitor) Orladeyo (Berotralstat) Takhzyro (Lanadelumab) Ruconest (Recombinant human C1-esterase inhibitor) Firazyr (Icatibant injection) Icatibant - any brand except Firazyr | |
| Answer To Question 1: Please find attached word document containing Q1 response To accompany this answer to question 1 please also see the documents listed below:  FOI 8801 - question 1.pdf | |
| Question Number 2: IG In the past 3 months how many patients have received the following treatment for any disease: Octagam Gamunex Intratect Kiovig Gamten Panzyga Xembify Cuvitru Cutaquig Hyqvia | |
| Answer To Question 2: Octagam <5 patients, Gamunex 11 patients, Intractect <5 patients, Kiovig/Xembify/Cuvitru/Cutaquig/Hyqvia zero patients, Gamten 16 patients, Panzyga <5 patients | |
| Question Number 3: In the past 3 months, how many patients have received any immunoglobulin treatment for the following diseases: Primary immunodeficiency (PID) Secondary immunodeficiency (SID) Chronic Inflammatory Demyelinating Polyneuropathy (CIDP) | |
| Answer To Question 3: PID 5 patients, SID 17 patients, CIDP 7 patients | |
| Please see Attachments: | |
| To return to the list of all the FOI requests please click here | |
Our staff at SA国际传媒 Hospital have long been well regarded for the quality of care and treatment they provide for our patients and for their innovation, commitment and professionalism. This has been recognised in a wide range of achievements and it is reflected in our award of NHS Foundation Trust status. This is afforded to hospitals that provide the highest standards of care.
